HORMONAL THERAPY IN CANCER OF THE BREAST. 23. EFFECT OF 7-ALPHA-METHYL-19-NORTESTOSTERONE ACETATE AND TESTOSTERONE PROPIONATE ON CLINICAL COURSE AND HORMONAL EXCRETION.
D015068:17-Ketosteroids; D000085:Acetates; D000970:Antineoplastic Agents; D001663:Bilirubin; D035843:Biomedical Research; D001786:Blood Glucose; D001943:Breast Neoplasms; D005260:Female; D005441:Fluids and Secretions; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006801:Humans; D007677:Kidney Function Tests; D009277:Nandrolone / Q000031:analogs & derivatives; D009369:Neoplasms; D009584:Nitrogen; D011388:Prolactin; D013739:Testosterone / Q000627:therapeutic use*; D043343:Testosterone Propionate; D014116:Toxicology; D000637:Transaminases; D014508:Urea; D014556:Urine; D014770:Virilism
D015068:17-Ketosteroids; D000085:Acetates; D000970:Antineoplastic Agents; D001786:Blood Glucose; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D013739:Testosterone; C013042:trestolone acetate; D009277:Nandrolone; D014508:Urea; D011388:Prolactin; D000637:Transaminases; D009584:Nitrogen; D001663:Bilirubin; D043343:Testosterone Propionate
17-KETOSTEROIDS; AMINOTRANSFERASES; ANTINEOPLASTIC AGENTS; BILIRUBIN; BLOOD SUGAR; BREAST NEOPLASMS; CLINICAL RESEARCH; EXCRETION; GONADOTROPINS, PITUITARY; KIDNEY FUNCTION TESTS; NANDROLONE; NITROGEN; PROLACTIN; TESTOSTERONE, THERAPEUTIC; TOXICOLOGIC REPORT; UREA; URINE; VIRILISM